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Abstract
Saffold cardiovirus, a newly discovered human cardiovirus, has close similarity
with Theiler’s murine encephalomyelitis virus (TMEV) which can cause a
chronic demyelinating encephalomyelitis in mice. In this study, we tested
whether Saffold cardiovirus infection of the brain is associated with multiple
sclerosis (MS). Autopsy white matter samples from 19 MS and 9 normal brain
donors were tested by polymerase chain reaction. All were negative. Paired cere-
brospinal fluid and serum samples from 24 MS patients and 27 controls were
tested for Saffold cardiovirus-specific oligoclonal bands, two patients and two
controls reacted positive. We conclude that an association between Saffold
cardiovirus and MS is highly improbable.
Introduction
The possible relation between multiple sclerosis (MS) and
viruses has a long-standing history. In spite of extensive
searches, data that reach beyond an association have not
been produced.1 The search for causal viruses is fuelled
by epidemiological data suggesting an infectious trigger
and by the enigmatic specificity of unique oligoclonal IgG
bands (OCB) that are found in the cerebrospinal fluid of
~95% of MS patients and reflect intrathecal IgG synthe-
sis.2,3 Several of the OCBs have antiviral reactivity as can
be found in response to central nervous system (CNS)
infections. Moreover, a substantial proportion of the B
cells in the CNS of MS patients have characteristics of
antibody secreting plasma blasts, suggesting ongoing anti-
genic stimulation and inflammation.4 The latter is con-
cordant with a chronic infection of which autoimmunity
may be a consequence.5
Another reason for revisiting the subject is the discov-
ery of Saffold cardiovirus (SAFV) which is the first
human virus species belonging to the genus Cardiovirus.6
Cardioviruses are well-known pathogens in rodents and
Theiler’s murine encephalomyelitis virus (TMEV) is a
prototype mouse cardiovirus that can cause a chronic
encephalomyelitis with demyelination showing many sim-
ilarities with MS (reviewed in reference [7]).
SAFV has a close genetic similarity with Theiler’s like
cardioviruses of rodents and has therefore also been
named Human Theiler’s like Cardiovirus (HTCV).8 By
analogy, a relationship of SAFV infection with MS should
be considered. So far, only one group has studied whether
SAFV RNA sequences can be detected in cerebro spinal
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fluid (CFS) samples from MS patients but with negative
results.8
Previously, we have shown that SAFV infections in
humans are ubiquitous and occur early in life.9,10 Up to
now, no clear illness has been attributed to SAFV infec-
tions and the virus has rarely been detected in CSF.8,11–13
Here, we present an in-depth search for SAFV RNA
sequences in brain samples from MS patients and whether
the unique OCB in CSF of MS patients do recognize
SAFV antigens.
Materials and Methods
Patients and specimens
Postmortem white matter brain tissue from 19 MS
patients and 9 brain donors without brain disease was
obtained from the Netherlands Brain Bank (www.brain-
bank.nl). Both MS patients and donors had given
informed consent for brain autopsy and for use of tissue
and clinical information for research purposes. The qual-
ity of brain tissue was assessed by measurement of pH
and of RNA integrity measured on an Agilent 2100 Bio-
analyser (Agilent Technologies, San Diego, CA) and
expressed in RNA Integrity Numbers (RIN).14 In the
brain samples used for this study the pH ranged
between 6.1 and 7.2. None of the specimens had a RIN
value below six (indicating substantial RNA breakdown).
RIN values ≥6 were previously shown not to affect RT-
qPCR efficiency for reference genes (unpublished obser-
vations). Clinical diagnoses of MS were confirmed by a
neurologist (Prof. C. H. Polman, VUmc, Amsterdam,
the Netherlands). The MS brain donors (2 males and 17
females) had a median age of 62 years (range 38–84).
Seventeen of the 19 MS brains contained still active
white matter lesions (HLA DR+ and/or PLP+ macro-
phages), 12 of the 19 MS brains showed even more than
50% active lesions.15,16 From 6 of the 19 MS patients,
thick cryostat sections of active MS lesions were directly
tested by polymerase chain reaction (PCR). All other
specimens were normal appearing white matter
(NAWM). The nine white matter specimens from
donors without a brain disease were derived from one
male and eight females with a median age of 61 years,
range 41–82.
Paired CSF and serum samples drawn for diagnostic
routine were available from the Neurology Department in
Nijmegen. The samples were from 24 MS patients, 7
males and 17 females, with a median age of 42 years,
range 24–66, and from 27 patients with other illnesses (7
males and 19 females, median age 41 years, range 32–59).
For one control subject information on gender and age is
lacking. Permission for anonymous testing of these sam-
ples fulfilled the terms of the ethical code “Goed Gebruik”
of the Netherlands Federation of Medical Scientific
Societies (Federa).
Virus antigens
For antigen production, a SAFV type 3 strain was grown
in HeLa cells as reported earlier.9 The culture supernatant
was concentrated by Amicon filtration. The final prepara-
tion had a protein concentration of 65 mg/mL and a
virus titer of 3x10e11.
Real-time PCR
Brain tissue samples were homogenized by bead beating
(Roche Diagnostics, Almere, The Netherlands), and
nucleic acid isolation, copyDNA synthesis, and real-time
PCR (50 cycles of 95°C for 15 sec and 60°C for 45 sec)
were performed essentially as described previously,17 using
SAFV-specific primers (GCTGGGGTTGCACCGCTA and
GAGCCTCTGCGGCC AAA) and a hydrolysis probe
(6FAM-ACAGCAGTGG ATCTTATCCACGGGGC-BBQ).
Positive and negative controls for isolation, reverse tran-
scription, and PCR were included in each run.17 The
detection limit was less than 10 infectious units/mL.
Immunoblotting technique
Immunoblotting was performed, essentially as described
by Sindic et al.18 Briefly, equal amounts of IgG (250 ng)
purified from paired CSF and blood samples, were sepa-
rated by isoelectric focusing. Next, the agarose gels were
blotted on a sheet of nitrocellulose that was pretreated by
saturation with viral antigen (65 mg/sheet) and blocking
with Phosphate Buffered Saline (PBS) containing 3%
Bovine Serum Albumin. After washing, the blots were
incubated with alkaline phosphatase-conjugated goat anti-
human IgG at a 1:2500 dilution and stained with nitro
blue tetrazolium.
Results
Detection of SAFV genomic RNA in brain
lesions from MS patients
After invasion of the CNS, a virus can either behave as an
immunological trigger of autoimmunity and disappear
(“hit-and-run” model) or establish a low-grade persistent
infection accompanied by inflammation, demyelination,
and autoimmunity as found in animal models of MS.7,19
To test for the option of a low-grade chronic infection,
autopsy samples of brains from 19 MS patients (17 with
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active lesions on microscopy) were tested by a highly sen-
sitive RT-PCR for SAFV genomes. All samples reacted
negative (data not shown). Nine additional brain samples
without signs of MS or another inflammatory process that
were tested for comparison were also negative. Thus, we
concluded that a chronic SAFV infection of the brain in
MS is highly unlikely.
Virus-specific immunoblotting
In case of the “hit-and-run” option, a neuro-invasive
infection will probably leave an immunological imprint
behind of intrathecal IgG antibodies.20 CSF was analyzed
for intrathecal synthesis of SAFV antibodies by means of
the immunoblotting technique that tests unique OCB for
their reactivity with the virus. We tested paired CSF and
blood samples from 25 MS patients and 27 patients with-
out a neuro-inflammatory condition. As illustrated in the
Figure 1, some CSF samples showed unique reactivity
with SAFV antigens, whereas no reactivity was found in
serum. In total, 2 of 25 CSF samples from MS patients
and 2 of 27 control CSF samples showed SAFV antigen
reactivity, refuting a direct association of SAFV infection
with MS.
Discussion
Although SAFVs have only recently been discovered,
serologic epidemiology showed that infections are
ubiquitous and acquired early in life.9,10 Ubiquity sug-
gests moreover that SAFVs must have a long-standing
history of infecting mankind. The large majority of
SAFV infections are asymptomatic or mild and a clear
disease association still awaits discovery.11 Little is yet
known about the pathophysiology of SAFV infections
other than that the infections are ubiquitous, mostly
pass unnoticed, but sporadically present with a serious
CNS infection.12,13 This picture shows close similarity
with TMEV infections of mice, which are widespread in
nature and cause very sporadically an MS-like chronic
demyelinating illness, actually only when genetically sus-
ceptible mice become infected by a unique variant of
TMEV.7 By analogy, a relationship of MS with SAFV
infection could have been the rare outcome of a chronic
encephalomyelitis caused only by particular SAFV strains
and only when occurring in genetically predisposed indi-
viduals. In this manner, a ubiquitous virus (SAFV)
could have been the cause of MS, fulfilling a condition
of monocausality: one virus, one disease, as discussed by
Lipton and colleagues.19
However, in our study we found no support for a
chronic SAFV infection in MS brains. We applied a
highly sensitive RT-PCR and tested selected brain speci-
men from 19 autopsy-confirmed MS patients, 12 of 19
specimens were highly selected samples from areas with
inflammation. None reacted positive, making the chance
of having missed a slowly ongoing chronic encephalomy-
elitis very small: its existence in MS must be quite
improbable. These findings are corroborated by a negative
PCR in CSF samples from 40 MS patients reported ear-
lier.8
Considering that a chronic SAFV encephalomyelitis
may have died out by gain of an adequate intracerebral
immune response, one may expect that an antibody
imprint will still be detectable as has been demonstrated
for herpes simplex virus encephalitis.20 To test this possi-
bility, we applied a specific immunostaining technique to
detect SAFV antigen-specific OCB. In 2 of 25 MS patients
we found indeed evidence for intrathecal IgG OCB that
reacted with SAFV antigens, but such OCB were also
found in 2 of 27 controls. Thus, SAFV-specific OCB can
sometimes be detected in CSF but without a clear associa-
tion with MS. Because of anonymous testing of the paired
serum and CSF samples we were not informed on the
medical history of the positive patients.
In conclusion, evidence for SAFV infection of the brain
was not found and even an association of MS with a past
SAFV infection was not found. We conclude that,
Figure 1. Immunoblot staining for SAF virus-specific oligoclonal IgG
bands in two multiple sclerosis (MS) patients. The figure shows paired
serum and CSF oligoclonal IgG blots from two MS patients: lanes 1
(serum) and 2 (CSF) show a mirror pattern of SAF virus-specific IgG
bands; lanes 3 (serum) and 4 (CSF) from a second MS patient show
unique SAF virus-specific IgG bands in CSF only.
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although one cannot exclude an etiological role of SAFV
infections in MS from a single study, a monocausal rela-
tionship, for example, by chronic infection of the brain,
will be improbable.
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